Table 2 Conversion data at 12 months by ethnicity
Conversion | N | Mean (SD) Tac-BID dose (mg/day) | Mean (SD) [Tac] bid (ng/ml) | Mean (SD) Tac-OD dose (mg/day) | Mean (SD) [Tac] OD (ng/ml) | Percentage of cohort requiring >30% increase in Tac-OD dose |
|---|---|---|---|---|---|---|
Total | 488 | 3.53 (2.01) | 5.49 (2.36) | 3.75 (2.03) | 5.15 (2.48) | 15.7 |
Caucasian | 282 | 3.23 (1.94) | 5.58 (2.34) | 3.42 (2.14) | 5.48 (2.93) | 13.5 |
East Asian | 91 | 3.59 (2.27) | 5.46 (2.35) | 4.07 (2.28) | 4.64 (1.38) | 27.5* |
South Asian | 75 | 3.67 (2.25) | 5.00 (1.62) | 3.86 (2.31) | 4.54 (1.38) | 8.0 |
African Canadian | 18 | 6.18 (3.87) | 5.13 (1.43) | 6.23 (4.20) | 5.92 (2.33) | 11.1 |
Middle Eastern | 12 | 3.04 (1.76) | 6.39 (3.26) | 2.96 (1.57) | 4.70 (2.30) | 8.3 |
Other | 10 | 2.89 (2.33) | 5.42 (2.37) | 2.06 (2.14) | 5.40 (2.31) | 20.0 |